##gff-version 3
##sequence-region Q9UJU2 1 399
Q9UJU2	UniProtKB	Chain	1	399	.	.	.	ID=PRO_0000048595;Note=Lymphoid enhancer-binding factor 1	
Q9UJU2	UniProtKB	DNA binding	299	367	.	.	.	Note=HMG box;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00267	
Q9UJU2	UniProtKB	Region	1	62	.	.	.	Note=CTNNB1-binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9UJU2	UniProtKB	Compositional bias	6	13	.	.	.	Note=Poly-Gly	
Q9UJU2	UniProtKB	Compositional bias	14	52	.	.	.	Note=Asp/Glu-rich (acidic)	
Q9UJU2	UniProtKB	Compositional bias	77	273	.	.	.	Note=Pro-rich	
Q9UJU2	UniProtKB	Compositional bias	374	379	.	.	.	Note=Poly-Lys	
Q9UJU2	UniProtKB	Modified residue	132	132	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19690332;Dbxref=PMID:19690332	
Q9UJU2	UniProtKB	Modified residue	155	155	.	.	.	Note=Phosphothreonine%3B by NLK;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:12556497;Dbxref=PMID:12556497	
Q9UJU2	UniProtKB	Modified residue	166	166	.	.	.	Note=Phosphoserine%3B by NLK;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:12556497;Dbxref=PMID:12556497	
Q9UJU2	UniProtKB	Cross-link	27	27	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9UJU2	UniProtKB	Cross-link	269	269	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9UJU2	UniProtKB	Alternative sequence	1	115	.	.	.	ID=VSP_007022;Note=In isoform 3 and isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
Q9UJU2	UniProtKB	Alternative sequence	1	70	.	.	.	ID=VSP_044877;Note=In isoform 7. MPQLSGGGGGGGGDPELCATDEMIPFKDEGDPQKEKIFAEISHPEEEGDLADIKSSLVNESEIIPASNGH->MA;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9UJU2	UniProtKB	Alternative sequence	214	241	.	.	.	ID=VSP_040068;Note=In isoform 5%2C isoform 6 and isoform 7. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:19653274;Dbxref=PMID:14702039,PMID:15489334,PMID:19653274	
Q9UJU2	UniProtKB	Alternative sequence	283	399	.	.	.	ID=VSP_002188;Note=In isoform 2 and isoform 4. KPQHEQRKEQEPKRPHIKKPLNAFMLYMKEMRANVVAECTLKESAAINQILGRRWHALSREEQAKYYELARKERQLHMQLYPGWSARDNYGKKKKRKREKLQESASGTGPRMTAAYI->CSAFLLPHPFLIPSTPSPNHHHHHLLGSLSMNRERSRSQKDLTLRSL;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
Q9UJU2	UniProtKB	Alternative sequence	390	399	.	.	.	ID=VSP_040069;Note=In isoform 6. TGPRMTAAYI->GKRSSFPTCKAKAATPGPLLEMEAC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9UJU2	UniProtKB	Natural variant	113	113	.	.	.	ID=VAR_035935;Note=In a colorectal cancer sample%3B somatic mutation. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=dbSNP:rs369649181,PMID:16959974	
Q9UJU2	UniProtKB	Mutagenesis	155	155	.	.	.	Note=Reduced phosphorylation by NLK%3B when associated with A-166. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12556497;Dbxref=PMID:12556497	
Q9UJU2	UniProtKB	Mutagenesis	166	166	.	.	.	Note=Reduced phosphorylation by NLK%3B when associated with A-155. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12556497;Dbxref=PMID:12556497	
Q9UJU2	UniProtKB	Sequence conflict	146	146	.	.	.	Note=Q->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
